114 related articles for article (PubMed ID: 38449090)
1. Identification of ANKRD13D as a potential target in renal cell carcinomas.
Zhou W; Huang Y; Liu J; Liu Y; Liu Y; Yu C
Int J Biol Markers; 2024 Jun; 39(2):149-157. PubMed ID: 38449090
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
Song J; Yang R; Wei R; Du Y; He P; Liu X
Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
[TBL] [Abstract][Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
Cao H; Zhang J; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma.
Xu F; Guan Y; Zhang P; Xue L; Yang X; Gao K; Chong T
Genes Genomics; 2020 Sep; 42(9):1055-1066. PubMed ID: 32725578
[TBL] [Abstract][Full Text] [Related]
7. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
[TBL] [Abstract][Full Text] [Related]
8. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
Zou X; Mo Z
Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
[TBL] [Abstract][Full Text] [Related]
9. Multi-Omics Analysis of the Prognosis and Biological Function for TRPV Channel Family in Clear Cell Renal Cell Carcinoma.
Jiang Y; Han D; Zhao Y; Zhang C; Shi X; Gu W
Front Immunol; 2022; 13():872170. PubMed ID: 35558077
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
11. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.
Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C
BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262
[TBL] [Abstract][Full Text] [Related]
12. The Correlation of HK2 Gene Expression with the Occurrence, Immune Cell Infiltration, and Prognosis of Renal Cell Carcinoma.
Liu C; Li H; Huang H; Zheng P; Li Z
Dis Markers; 2022; 2022():1452861. PubMed ID: 35265223
[TBL] [Abstract][Full Text] [Related]
13. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of NEK2 is correlated with poor prognosis in human clear cell renal cell carcinoma.
Wang C; Huang Y; Ma X; Wang B; Zhang X
Int J Immunopathol Pharmacol; 2021; 35():20587384211065893. PubMed ID: 34910592
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma.
Li J; Liu C; Su H; Dong H; Wang Z; Wang Y; Zhao P; Zhang C; Zhao Y; Ma X
Aging (Albany NY); 2024 Jan; 16(3):2161-2180. PubMed ID: 38277212
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
17. Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma.
Gui Y; Liu X; Wang C; Yang P
World J Surg Oncol; 2021 Apr; 19(1):111. PubMed ID: 33845847
[TBL] [Abstract][Full Text] [Related]
18. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
[TBL] [Abstract][Full Text] [Related]
19.
Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
[TBL] [Abstract][Full Text] [Related]
20. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
